Celestica, Inc. $CLS Shares Bought by Brookstone Capital Management

Brookstone Capital Management raised its holdings in shares of Celestica, Inc. (NYSE:CLS) (TSE:CLS) by 375.0% in the 1st quarter, HoldingsChannel reports. The fund owned 14,145 shares of the technology company’s stock after buying an additional 11,167 shares during the quarter. Brookstone Capital Management’s holdings in Celestica were worth $3,984,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Celestica in the fourth quarter valued at $28,000. Swiss RE Ltd. acquired a new position in Celestica in the fourth quarter valued at $29,000. Cullen Frost Bankers Inc. acquired a new stake in shares of Celestica during the fourth quarter worth about $30,000. Sittner & Nelson LLC purchased a new position in shares of Celestica in the 4th quarter valued at approximately $31,000. Finally, Atlantic Edge Private Wealth Management LLC purchased a new position in Celestica in the 4th quarter valued at $38,000. 67.38% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Michael Max Wilson sold 4,168 shares of Celestica stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the sale, the director directly owned 24,718 shares of the company’s stock, valued at approximately $8,238,756.58. The trade was a 14.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Mandeep Chawla sold 17,000 shares of Celestica stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $399.65, for a total value of $6,794,050.00. Following the sale, the chief financial officer owned 82,444 shares in the company, valued at $32,948,744.60. This represents a 17.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 161,168 shares of company stock worth $63,190,485 over the last ninety days. Corporate insiders own 1.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Zacks Research downgraded shares of Celestica from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. JPMorgan Chase & Co. upped their target price on shares of Celestica from $410.00 to $425.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 29th. Barclays lifted their price objective on Celestica from $391.00 to $441.00 and gave the stock an “overweight” rating in a report on Wednesday, April 29th. BMO Capital Markets increased their target price on Celestica from $370.00 to $450.00 and gave the company an “outperform” rating in a report on Friday, April 24th. Finally, Royal Bank Of Canada upped their price objective on shares of Celestica from $400.00 to $440.00 and gave the company an “outperform” rating in a research note on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.42.

Celestica Stock Performance

Shares of CLS stock opened at $363.12 on Thursday. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36. The company has a market cap of $41.75 billion, a PE ratio of 43.91, a P/E/G ratio of 0.82 and a beta of 2.02. The company’s fifty day simple moving average is $384.39 and its 200-day simple moving average is $327.58. Celestica, Inc. has a 52 week low of $144.27 and a 52 week high of $474.02.

Celestica (NYSE:CLS) (TSE:CLS) last announced its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.08. The firm had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The firm’s revenue was up 52.8% on a year-over-year basis. During the same period in the prior year, the company earned $1.20 EPS. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, equities research analysts anticipate that Celestica, Inc. will post 9.5 EPS for the current year.

Celestica Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.